Your browser doesn't support javascript.
loading
Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in Chinese females aged 9 to 26 years: A phase 3, open-label, immunobridging study.
Huang, Zhuhang; He, Jianfeng; Su, Jiali; Ou, Zhiqiang; Liu, Guixiu; Fu, Rong; Shou, Qiong; Zheng, Minghuan; Group, Thomas; Luxembourg, Alain; Liao, Xueyan; Zhang, Jikai.
Afiliación
  • Huang Z; Guangdong Provincial Institute of Biological Products and Materia Medica, 200 Xipengling Road, Guangzhou, Guangdong Province 510440, PR China.
  • He J; Guangdong Provincial Center for Disease Control and Prevention, 160 Qunxian Road, Guangzhou, Guangdong Province 511430, PR China.
  • Su J; Guangdong Provincial Institute of Biological Products and Materia Medica, 200 Xipengling Road, Guangzhou, Guangdong Province 510440, PR China.
  • Ou Z; Guangdong Provincial Institute of Biological Products and Materia Medica, 200 Xipengling Road, Guangzhou, Guangdong Province 510440, PR China.
  • Liu G; MSD R&D (China) Co., Ltd., 21 Rong Da Road, Beijing 100012, PR China. Electronic address: gui.xiu.liu@merck.com.
  • Fu R; MSD R&D (China) Co., Ltd., 21 Rong Da Road, Beijing 100012, PR China. Electronic address: rong.fu1@merck.com.
  • Shou Q; MSD R&D (China) Co., Ltd., 21 Rong Da Road, Beijing 100012, PR China. Electronic address: qiong.shou@merck.com.
  • Zheng M; MSD R&D (China) Co., Ltd., 21 Rong Da Road, Beijing 100012, PR China. Electronic address: ming.huan.zheng@merck.com.
  • Group T; Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. Electronic address: thomas_group@merck.com.
  • Luxembourg A; Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. Electronic address: alain_luxembourg@merck.com.
  • Liao X; MSD R&D (China) Co., Ltd., 21 Rong Da Road, Beijing 100012, PR China. Electronic address: xue.yan.liao@merck.com.
  • Zhang J; Guangdong Provincial Institute of Biological Products and Materia Medica, 200 Xipengling Road, Guangzhou, Guangdong Province 510440, PR China. Electronic address: 56061237@qq.com.
Vaccine ; 39(4): 760-766, 2021 01 22.
Article en En | MEDLINE | ID: mdl-33239228
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por Papillomavirus / Vacunas contra Papillomavirus Tipo de estudio: Guideline Límite: Adolescent / Adult / Child / Female / Humans / Middle aged País/Región como asunto: Asia Idioma: En Revista: Vaccine Año: 2021 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por Papillomavirus / Vacunas contra Papillomavirus Tipo de estudio: Guideline Límite: Adolescent / Adult / Child / Female / Humans / Middle aged País/Región como asunto: Asia Idioma: En Revista: Vaccine Año: 2021 Tipo del documento: Article Pais de publicación: Países Bajos